A meta-analysis of the pooled impact of CYP7A1 single nucleotide polymorphisms on serum lipid responses to statins

Background and Aims: Various publications suggested that there is an association between CYP7A1 single nucleotide polymorphisms (SNP) and a reduced response to statin therapy, but the results were inconsistent. This study aimed to collectively review these publications to appraise the effect of stat...

Full description

Bibliographic Details
Main Authors: Megan Yu Cai Lim, Jia Rong Tee, Wai-Ping Yau, Han Kiat Ho
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2023.1199549/full
_version_ 1797806034575687680
author Megan Yu Cai Lim
Jia Rong Tee
Wai-Ping Yau
Han Kiat Ho
author_facet Megan Yu Cai Lim
Jia Rong Tee
Wai-Ping Yau
Han Kiat Ho
author_sort Megan Yu Cai Lim
collection DOAJ
description Background and Aims: Various publications suggested that there is an association between CYP7A1 single nucleotide polymorphisms (SNP) and a reduced response to statin therapy, but the results were inconsistent. This study aimed to collectively review these publications to appraise the effect of statins on cholesterol control in carriers of CYP7A1 variant alleles.Methods: PUBMED, Cochrane and EMBASE were searched systematically to identify reported studies on the lipid responses to statin treatment between carriers of the variant allele versus the non-variant allele of CYP7A1 SNPs. The change from baseline in lipid responses for all included studies were calculated using weighted mean differences (WMD) (with 95% confidence interval (CI)). A meta-analysis was conducted to pool results using either the random-effects model or the fixed effects model.Results: A total of 6 publications comprising of 1,686 subjects for the assessment of total cholesterol, LDL-C and HDL-C and 1,156 subjects for the assessment of triglycerides were included in the meta-analyses. Subjects who were non-carriers of a CYP7A1 SNP (−204 A/C (rs3808607), −278 A/C (rs3808607) and rs8192875) had a greater reduction in total cholesterol (overall WMD -0.17, 95% CI -0.29, −0.06) and LDL-C levels (overall WMD -0.16, 95% CI -0.26, −0.05) as compared with subjects who borne the variant allele of CYP7A1 SNPs when administered a statin.Conclusion: The presence of variant allele of CYP7A1 SNPs may result in suboptimal control of total cholesterol and LDL-C levels as compared with individuals who do not carry the variant allele, when administered an equivalent dose of statin.
first_indexed 2024-03-13T06:01:09Z
format Article
id doaj.art-72ea7b34c17247adbadefe8751c420c6
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-03-13T06:01:09Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-72ea7b34c17247adbadefe8751c420c62023-06-12T15:46:22ZengFrontiers Media S.A.Frontiers in Genetics1664-80212023-06-011410.3389/fgene.2023.11995491199549A meta-analysis of the pooled impact of CYP7A1 single nucleotide polymorphisms on serum lipid responses to statinsMegan Yu Cai Lim0Jia Rong Tee1Wai-Ping Yau2Han Kiat Ho3Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, SingaporeDepartment of Mathematics, Faculty of Science, National University of Singapore, Singapore, SingaporeDepartment of Pharmacy, Faculty of Science, National University of Singapore, Singapore, SingaporeDepartment of Pharmacy, Faculty of Science, National University of Singapore, Singapore, SingaporeBackground and Aims: Various publications suggested that there is an association between CYP7A1 single nucleotide polymorphisms (SNP) and a reduced response to statin therapy, but the results were inconsistent. This study aimed to collectively review these publications to appraise the effect of statins on cholesterol control in carriers of CYP7A1 variant alleles.Methods: PUBMED, Cochrane and EMBASE were searched systematically to identify reported studies on the lipid responses to statin treatment between carriers of the variant allele versus the non-variant allele of CYP7A1 SNPs. The change from baseline in lipid responses for all included studies were calculated using weighted mean differences (WMD) (with 95% confidence interval (CI)). A meta-analysis was conducted to pool results using either the random-effects model or the fixed effects model.Results: A total of 6 publications comprising of 1,686 subjects for the assessment of total cholesterol, LDL-C and HDL-C and 1,156 subjects for the assessment of triglycerides were included in the meta-analyses. Subjects who were non-carriers of a CYP7A1 SNP (−204 A/C (rs3808607), −278 A/C (rs3808607) and rs8192875) had a greater reduction in total cholesterol (overall WMD -0.17, 95% CI -0.29, −0.06) and LDL-C levels (overall WMD -0.16, 95% CI -0.26, −0.05) as compared with subjects who borne the variant allele of CYP7A1 SNPs when administered a statin.Conclusion: The presence of variant allele of CYP7A1 SNPs may result in suboptimal control of total cholesterol and LDL-C levels as compared with individuals who do not carry the variant allele, when administered an equivalent dose of statin.https://www.frontiersin.org/articles/10.3389/fgene.2023.1199549/fullpharmacogenomicsCYP7A1single nucleotide polymorphismsstatinslipid response
spellingShingle Megan Yu Cai Lim
Jia Rong Tee
Wai-Ping Yau
Han Kiat Ho
A meta-analysis of the pooled impact of CYP7A1 single nucleotide polymorphisms on serum lipid responses to statins
Frontiers in Genetics
pharmacogenomics
CYP7A1
single nucleotide polymorphisms
statins
lipid response
title A meta-analysis of the pooled impact of CYP7A1 single nucleotide polymorphisms on serum lipid responses to statins
title_full A meta-analysis of the pooled impact of CYP7A1 single nucleotide polymorphisms on serum lipid responses to statins
title_fullStr A meta-analysis of the pooled impact of CYP7A1 single nucleotide polymorphisms on serum lipid responses to statins
title_full_unstemmed A meta-analysis of the pooled impact of CYP7A1 single nucleotide polymorphisms on serum lipid responses to statins
title_short A meta-analysis of the pooled impact of CYP7A1 single nucleotide polymorphisms on serum lipid responses to statins
title_sort meta analysis of the pooled impact of cyp7a1 single nucleotide polymorphisms on serum lipid responses to statins
topic pharmacogenomics
CYP7A1
single nucleotide polymorphisms
statins
lipid response
url https://www.frontiersin.org/articles/10.3389/fgene.2023.1199549/full
work_keys_str_mv AT meganyucailim ametaanalysisofthepooledimpactofcyp7a1singlenucleotidepolymorphismsonserumlipidresponsestostatins
AT jiarongtee ametaanalysisofthepooledimpactofcyp7a1singlenucleotidepolymorphismsonserumlipidresponsestostatins
AT waipingyau ametaanalysisofthepooledimpactofcyp7a1singlenucleotidepolymorphismsonserumlipidresponsestostatins
AT hankiatho ametaanalysisofthepooledimpactofcyp7a1singlenucleotidepolymorphismsonserumlipidresponsestostatins
AT meganyucailim metaanalysisofthepooledimpactofcyp7a1singlenucleotidepolymorphismsonserumlipidresponsestostatins
AT jiarongtee metaanalysisofthepooledimpactofcyp7a1singlenucleotidepolymorphismsonserumlipidresponsestostatins
AT waipingyau metaanalysisofthepooledimpactofcyp7a1singlenucleotidepolymorphismsonserumlipidresponsestostatins
AT hankiatho metaanalysisofthepooledimpactofcyp7a1singlenucleotidepolymorphismsonserumlipidresponsestostatins